CBmed GmbH

Season's Greetings from all of us at 𝐂𝐁𝐦𝐞𝐝! 🎄 As we wrap up 2024 (and our 10th Anniversary 🥳), we’re feeling extra grateful for all the amazing people who make what we do possible. To our partners, collaborators, and supporters: THANK YOU! 🙌 Your trust, vision, and enthusiasm keep us pushing the boundaries of #precisionmedicine and striving for excellence every single day. Wishing you and your loved ones a holiday season filled with joy, laughter, and unforgettable moments. May the New Year bring success, good health, and exciting new adventures. Here's to bidding farewell to 2024 with gratitude and welcoming an even brighter 2025! 🌟 Happy holidays and an amazing New Year from the entire CBmed team! 💜 #SeasonsGreetings #HappyHolidays #CBmed10Years #CheersTo2024 #NewYear2025 #CBmedJourneyContinues

We’re excited to share the success of the 𝐅𝐢𝐫𝐬𝐭 𝐀𝐮𝐬𝐭𝐫𝐢𝐚𝐧 𝐃𝐫𝐮𝐠 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐍𝐞𝐭𝐰𝐨𝐫𝐤𝐢𝐧𝐠 𝐌𝐞𝐞𝐭𝐢𝐧𝐠, where we made significant strides in strengthening Austria’s #drugscreening community and building connections across Europe. CBmed GmbH was proud to host and bring together researchers, innovators, and stakeholders to share insights, exchange expertise, and explore strategies for advancing drug screening initiatives. A special highlight was the visit of Dr. Philip Gribbon from the EU-OPENSCREEN, who shared valuable insights into the network's initiatives, its members, and their contributions to advancing drug screening across Europe. His presentation emphasized the importance of collaborative efforts in accelerating #drugdiscovery and fostering innovation. It was incredible to witness the enthusiasm and collaboration that set the foundation for impactful partnerships and future innovation. 🤝 A heartfelt thank you to everyone who joined and contributed to making this meeting such a success! Your energy and ideas are driving meaningful progress in this field. Stay tuned for updates as we continue building on these efforts—this is just the beginning! Thomas Pieber, Barbara Prietl, Maximilian Kramer-Drauberg, Stefanie Stanzer, Vanessa Stadlbauer-Köllner, Bahne STECHMANN, Tadeja Urbanic, Anna Sophie Berghoff, Zoltan Spiro, PhD #CBmed #euopenscreen #collaboration #innovation #drugscreening #networking

Greetings from Utrecht and the MOMENTUM Microplastics Meetings!👋 We’re thrilled to share highlights from the final MOMENTUM 1.0 and the bi-annual MOMENTUM 2.0 Consortium Meetings, held on the 27th and 28th of November 2024 in Utrecht. This gathering brings together experts, researchers, and collaborators to advance our understanding of how #microplastics impact #humanhealth. As part of the Consortium, CBmed GmbH is actively contributing to these important discussions. Our very own 𝐀𝐧𝐠𝐞𝐥𝐚 𝐇𝐨𝐫𝐯𝐚𝐭𝐡 and Lukas Kenner from the 𝐦𝐢𝐜𝐫𝐨𝐎𝐍𝐄 project shared some fantastic moments from the event!🤩 The discussions don’t stop here — tomorrow, the dialogue continues at the 3𝐫𝐝 𝐦𝐢𝐜𝐫𝐨𝐍𝐄 𝐒𝐮𝐦𝐦𝐢𝐭 𝐢𝐧 𝐆𝐫𝐚𝐳, diving deeper into the crucial issues surrounding #microplasticsresearch. 👀 Stay tuned for more updates and insights from this growing network of collaboration. 🔎 𝐦𝐢𝐜𝐫𝐨𝐎𝐍𝐄, a project funded within the COMET Module programme, is a pioneering initiative at the forefront of microplastics research whose aim is to investigate the effects of micro- and nanoplastic particles (MNPs) in the human body. The research is carried out at the CBmed research center together with over 20 partner organizations worldwide, including renowned universities and research institutions. Discover more about microONE and gain insight into groundbreaking research on microplastic contamination at 👉www.microone.at 𝐌𝐎𝐌𝐄𝐍𝐓𝐔𝐌 is a research consortium spearheaded by Utrecht University that aims to unravel the effects of exposure to micro- and nanoplastic particles (MNPs) on human health and propose solutions to minimize their potential health impact. Learn more about MOMENTUM at 👉https://lnkd.in/ed-UfPPm #CBmed #microONE #MOMENTUMConsortium #microplastics #humanhealth #researchcollaboration

Exciting Updates from CBmed's research project on #liquidbiopsy in cancer! We’re thrilled to share some recent milestones from our collaboration with the Medizinische Universität Graz and QIAGEN: ✨ Last week, Prof. Amin El-Heliebi and 𝐌𝐚𝐫𝐠𝐚𝐫𝐞𝐭 𝐙𝐢𝐧𝐧𝐞𝐠𝐞𝐫 represented our project at the prestigious European Association for Cancer Research (EACR) 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐢𝐞𝐬 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 in Lyon. Prof. El-Heliebi not only submitted a poster abstract but was also selected for a 𝐬𝐩𝐨𝐭𝐥𝐢𝐠𝐡𝐭 𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧, highlighting our innovative work in liquid biopsy research. 📄 Our groundbreaking research has reached another milestone with the publication of a new paper: “𝑨𝒅𝒗𝒂𝒏𝒄𝒆𝒅 𝒔𝒊𝒏𝒈𝒍𝒆-𝒄𝒆𝒍𝒍 𝒂𝒏𝒅 𝒔𝒑𝒂𝒕𝒊𝒂𝒍 𝒂𝒏𝒂𝒍𝒚𝒔𝒊𝒔 𝒘𝒊𝒕𝒉 𝒉𝒊𝒈𝒉-𝒎𝒖𝒍𝒕𝒊𝒑𝒍𝒆𝒙 𝒄𝒉𝒂𝒓𝒂𝒄𝒕𝒆𝒓𝒊𝒛𝒂𝒕𝒊𝒐𝒏 𝒐𝒇 𝒄𝒊𝒓𝒄𝒖𝒍𝒂𝒕𝒊𝒏𝒈 𝒕𝒖𝒎𝒐𝒓 𝒄𝒆𝒍𝒍𝒔 𝒂𝒏𝒅 𝒕𝒖𝒎𝒐𝒓 𝒕𝒊𝒔𝒔𝒖𝒆 𝒊𝒏 𝒑𝒓𝒐𝒔𝒕𝒂𝒕𝒆 𝒄𝒂𝒏𝒄𝒆𝒓: 𝑼𝒏𝒗𝒆𝒊𝒍𝒊𝒏𝒈 𝒓𝒆𝒔𝒊𝒔𝒕𝒂𝒏𝒄𝒆 𝒎𝒆𝒄𝒉𝒂𝒏𝒊𝒔𝒎𝒔 𝒘𝒊𝒕𝒉 𝒕𝒉𝒆 𝑪𝒐𝑫𝒖𝑪𝒐 𝒊𝒏 𝒔𝒊𝒕𝒖 𝒂𝒔𝒔𝒂𝒚” by Bonstingl et al. You can read it here: 👉https://lnkd.in/dVpXp4xj We are incredibly proud of the team and grateful for our partners as we continue pushing the boundaries of cancer research. 💡 Stay tuned for more updates on our journey to advance personalized medicine through liquid biopsy innovation! #CBmed #MedicalUniversityGraz #Qiagen #liquidbiopsy #cancerresearch #EACR #precisionmedicine #biomarkerresearch

📢 𝐓𝐡𝐞 𝐂𝐨𝐮𝐧𝐭𝐝𝐨𝐰𝐧 𝐢𝐬 𝐎𝐧! We're just one week away from the 3𝐫𝐝 𝐦𝐢𝐜𝐫𝐨𝐎𝐍𝐄 𝐒𝐮𝐦𝐦𝐢𝐭 𝐨𝐧 𝐌𝐢𝐜𝐫𝐨𝐩𝐥𝐚𝐬𝐭𝐢𝐜𝐬 𝐚𝐧𝐝 𝐇𝐞𝐚𝐥𝐭𝐡, hosted by CBmed GmbH, happening next Friday, November 29th, in the vibrant city of #Graz! This year, we're diving deep into a critical theme: 𝐌𝐍𝐏 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐢𝐧 𝐁𝐢𝐨𝐦𝐚𝐭𝐞𝐫𝐢𝐚𝐥𝐬: 𝐒𝐚𝐦𝐩𝐥𝐢𝐧𝐠, 𝐏𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠, 𝐚𝐧𝐝 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬.   The event will bring together leading experts and researchers to explore innovative approaches, share experiences, and advance progress in the critical field of #microplastics and #health. In addition, our annual #microONE consortium meeting will provide an invaluable opportunity for project board members to: ✔️ Reflect on our progress. ✔️ Collaborate on future initiatives. ✔️ Strengthen our collective efforts to meet the project’s ambitious goals. We’re looking forward to a day of meaningful discussions and collaboration to drive impactful change in the field. 💡Find out more: https://lnkd.in/dSw2NqVA 🔎 microONE, a project funded within the COMET Module programme, is a pioneering initiative at the forefront of microplastics research whose aim is to investigate the effects of micro-and nanoplastic particles (MNPs) in the human body. The research is carried out at the CBmed research center together with over 20 partner organizations worldwide, including renowned universities and research institutions. Discover more about microONE and gain insight into groundbreaking research on microplastic contamination at 👉www.microone.at FFG Austrian Research Promotion Agency, Steirische Wirtschaftsförderung SFG, Wirtschaftsagentur Wien, Medical University of Vienna, Medizinische Universität Graz, RECENDT GmbH - Research Center for Non-Destructive Testing, University of Vienna, JOANNEUM RESEARCH, University of Cambridge, University of Brescia, Universitätsklinikum Hamburg Eppendorf, University of Nottingham, Vilniaus universitetas / Vilnius University, INAM - Institut für Nanotechnologie und korrelative Mikroskopie gGmbh, THP Medical Products, Institut AllergoSan, Agilent Technologies, Winclove Probiotics, TissueGnostics, LISAvienna, Invisible-Light Labs GmbH, Immundiagnostik AG, bündnis mikroplastikfrei #CBmed #microONE #FFG #SFG #WAW #microplasticresearch #cometmodule #cancerresearch #humanhealth #microONESummit2024 #research #innovation

📣We are excited to share the publication of 𝐭𝐰𝐨 𝐤𝐞𝐲 𝐬𝐭𝐮𝐝𝐢𝐞𝐬 from CBmed GmbH, in collaboration with the 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐨𝐟 𝐆𝐫𝐚𝐳, exploring #probiotics as a potential aid in #COVID19recovery. Both articles have been published in Nutrients MDPI, with one featured as part of the Special Issue 𝘕𝘶𝘵𝘳𝘪𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘎𝘶𝘵 𝘔𝘪𝘤𝘳𝘰𝘣𝘪𝘰𝘵𝘢-𝘐𝘮𝘮𝘶𝘯𝘦 𝘚𝘺𝘴𝘵𝘦𝘮 𝘐𝘯𝘵𝘦𝘳𝘱𝘭𝘢𝘺 𝘪𝘯 𝘊𝘩𝘳𝘰𝘯𝘪𝘤 𝘋𝘪𝘴𝘦𝘢𝘴𝘦𝘴. 𝐊𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬: 🔹 𝐒𝐞𝐯𝐞𝐫𝐞 𝐂𝐚𝐬𝐞𝐬: Probiotics helped restore gut diversity, reduce inflammation, and improve quality of life, emphasizing the crucial role of the gut-lung axis in recovery. 🔹 𝐌𝐢𝐥𝐝 𝐂𝐚𝐬𝐞𝐬: Even mild COVID-19 infections significantly altered gut microbiota, with probiotics influencing microbial composition, though not impacting symptom recovery. The studies were led by Prof. Dr. Vanessa Stadlbauer-Köllner, and 𝐀𝐧𝐠𝐞𝐥𝐚 𝐇𝐨𝐫𝐯𝐚𝐭𝐡, PhD, showcasing the potential of microbiome-based therapies for improving recovery and emphasizing the need for further research. 💡Read the full articles to dive deeper into the findings and implications of this exciting research: 🔸 𝐀𝐥𝐭𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐆𝐮𝐭-𝐋𝐮𝐧𝐠 𝐀𝐱𝐢𝐬 𝐀𝐟𝐭𝐞𝐫 𝐒𝐞𝐯𝐞𝐫𝐞 𝐂𝐎𝐕𝐈𝐃-19 𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐌𝐨𝐝𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝐏𝐫𝐨𝐛𝐢𝐨𝐭𝐢𝐜𝐬: 𝐀 𝐑𝐚𝐧𝐝𝐨𝐦𝐢𝐳𝐞𝐝, 𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝 𝐏𝐢𝐥𝐨𝐭 𝐒𝐭𝐮𝐝𝐲: https://lnkd.in/d_qPvcC9 🔸𝐏𝐫𝐨𝐛𝐢𝐨𝐭𝐢𝐜 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐨𝐟 𝐆𝐚𝐬𝐭𝐫𝐨𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐚𝐥 𝐒𝐲𝐦𝐩𝐭𝐨𝐦𝐬 𝐃𝐮𝐫𝐢𝐧𝐠 𝐂𝐎𝐕𝐈𝐃-19 𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧: 𝐀 𝐑𝐚𝐧𝐝𝐨𝐦𝐢𝐳𝐞𝐝, 𝐃𝐨𝐮𝐛𝐥𝐞-𝐁𝐥𝐢𝐧𝐝, 𝐏𝐥𝐚𝐜𝐞𝐛𝐨-𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝, 𝐑𝐞𝐦𝐨𝐭𝐞 𝐒𝐭𝐮𝐝𝐲: https://lnkd.in/d7jXrBXP Visit our website for the press release and learn more about these exciting breakthroughs: 👉 https://lnkd.in/dvWR7x2u Hansjörg Habisch, Barbara Prietl, Verena Pfeifer, Irina Balazs, Gabor Kovacs, Vasile Foris, Nikolaus John, Daniela Klenschek, Nicole Feldbacher, Hennning Grønbæk, Holger Jon Møller, Kristina Ž., Tobias Madl, Rosa Haller, Medizinische Universität Graz, Institut AllergoSan, Winclove Probiotics, Aarhus University, FFG Austrian Research Promotion Agency, Austrian Science Fund FWF #CBmed #FFG #FWF #COVID19Recovery #microbiomeresearch #probiotics #gutlungaxis #healthcareinnovation

CBmed GmbH is thrilled to celebrate Lukas Kenner, who has received the 𝘙𝘦𝘤𝘵𝘰𝘳𝘢𝘵𝘦 𝘈𝘸𝘢𝘳𝘥 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘔𝘰𝘴𝘵 𝘊𝘪𝘵𝘦𝘥 𝘚𝘤𝘪𝘦𝘯𝘵𝘪𝘴𝘵 𝘢𝘵 𝘵𝘩𝘦 𝘜𝘯𝘪𝘷𝘦𝘳𝘴𝘪𝘵𝘺 𝘰𝘧 𝘝𝘦𝘵𝘦𝘳𝘪𝘯𝘢𝘳𝘺 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦 𝘝𝘪𝘦𝘯𝘯𝘢 for 2023/24! Presented by the Rectorate on November 7, 2024, this prestigious award highlights Lukas' remarkable contributions and lasting impact in the field, advancing scientific understanding and strengthening #collaborativeresearch. 👏 Our gratitude extends to the Vice-Rector for Science, 𝐏𝐫𝐨𝐟. 𝐎𝐭𝐭𝐨 𝐃𝐨𝐛𝐥𝐡𝐨𝐟𝐟-𝐃𝐢𝐞𝐫, for presenting this distinguished award and to all colleagues and collaborators whose support has been invaluable in achieving this milestone. Here’s to the journey ahead—committed to discovery, innovation, and excellence in veterinary and biomedical science! 🥂 #CBmed #microONE #VetmeduniVienn #researchexcellence #scienceinnovation #scientificimpact

We had the incredible opportunity to attend the 19th 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐀𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐍𝐞𝐮𝐫𝐨-𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 (𝐄𝐀𝐍𝐎) 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 in Glasgow, where our colleagues Barbara Prietl and 𝐒𝐭𝐞𝐟𝐚𝐧𝐢𝐞 𝐒𝐭𝐚𝐧𝐳𝐞𝐫 presented a poster on "𝘈𝘴𝘴𝘰𝘤𝘪𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘊𝘦𝘭𝘭𝘶𝘭𝘢𝘳 𝘋𝘳𝘶𝘨 𝘙𝘦𝘴𝘱𝘰𝘯𝘴𝘦𝘴 𝘢𝘯𝘥 𝘔𝘦𝘵𝘢𝘣𝘰𝘭𝘪𝘤 𝘗𝘳𝘰𝘧𝘪𝘭𝘦𝘴 𝘪𝘯 𝘈𝘥𝘶𝘭𝘵-𝘛𝘺𝘱𝘦 𝘋𝘪𝘧𝘧𝘶𝘴𝘦 𝘎𝘭𝘪𝘰𝘮𝘢𝘴." It was a privilege to share our latest findings and engage in discussions around cutting-edge neuro-oncology research. We were joined by our partners and colleagues including Tadeja Urbanic and Christoph Magnes, making it a truly collaborative experience. The event brought together professionals from diverse disciplines—Neuro-Oncology, Neurosurgery, Neuropathology, and more—fostering interdisciplinary exchange and innovation. The city of #Glasgow, with its rich history and welcoming atmosphere, was a fantastic backdrop for the congress. A huge thanks to #EANO for organizing such a successful and inspiring event. We look forward to future collaborations and advancements in the fight against central nervous system tumors! Medizinische Universität Graz, JOANNEUM RESEARCH #EANO2024 #NeuroOncology #gliomas #collaboration #cnstumors #scientificexchange

🎉Celebrating 10 Years of Excellence at CBmed!🎉 On September 23rd, we had the incredible honor of celebrating a decade of innovation, collaboration, and impact in #biomedicalresearch. This milestone was made even more special by the presence of our valued partners, shareholders, and government representatives—thank you for your unwavering support throughout our journey.🙌 As we reflect on our achievements, we also take pride in celebrating with the amazing team that has been the driving force behind CBmed’s success. Our anniversary party was filled with laughter, memories, and excitement for the future—because together, we are unstoppable!💪 Here’s to the past 10 years, and here’s to another decade of transforming healthcare through cutting-edge research, collaboration, and dedication!🚀 #CBmed #10YearAnniversary #10yearsofinnovation #decadeofdiscovery #precisionmedicine #biomedicalresearch #collaboration #celebration #futureforward 

🌟 We're at the 𝐄𝐒𝐌𝐎 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬 2024 in Barcelona! 🌟 It’s the final day at the #ESMO2024 Congress, and we’re excited to have Barbara Prietl and 𝐒𝐭𝐞𝐟𝐚𝐧𝐢𝐞 𝐒𝐭𝐚𝐧𝐳𝐞𝐫 at the event, showcasing our work throughout the congress and presenting our poster: 🔬 𝐋𝐢𝐧𝐤𝐢𝐧𝐠 𝐜𝐞𝐥𝐥𝐮𝐥𝐚𝐫 𝐝𝐫𝐮𝐠 𝐫𝐞𝐬𝐩𝐨𝐧𝐬𝐞𝐬 𝐭𝐨 𝐜𝐨𝐫𝐫𝐞𝐬𝐩𝐨𝐧𝐝𝐢𝐧𝐠 𝐦𝐞𝐭𝐚𝐛𝐨𝐥𝐨𝐦𝐢𝐜 𝐭𝐢𝐬𝐬𝐮𝐞 𝐬𝐢𝐠𝐧𝐚𝐭𝐮𝐫𝐞𝐬 𝐢𝐧 𝐠𝐥𝐢𝐨𝐦𝐚𝐬 If you’re attending today, don’t miss the chance to connect with us and explore our latest findings. Let’s discuss how we can drive the future of cancer research together! Catch us before the event wraps up! #CBmed #ESMO2024 #gliomas #cancerresearch #metabolomics